Trastuzumab-induced cardiotoxicity and its risk factors in real-world setting of breast cancer patients.

Tiina MoilanenAnna JokimäkiOlli TenhunenJussi Pekka Koivunen

Published in: Journal of cancer research and clinical oncology (2018)

Trastuzumab cardiotoxicity seems to accumulate among patients with underlying cardiac conditions. EF monitoring could be targeted to risk groups without compromising of the cardiac health or survival of HER2-positive breast cancer patients.

Keyphrases

risk factors
epidermal growth factor receptor
left ventricular
healthcare
public health
metastatic breast cancer
mental health
high glucose
diabetic rats
heart failure
human health